#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15596	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2052	752.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	904	C,T	837,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28052	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3681	758.4	0	.	n	.	0	T695C	SNP	695	695	T	1114	1114	C	862	C,T	806,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28052	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3681	758.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1756	1756	A	910	A,G	848,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28052	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3681	758.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2390	2390	C	933	C,T	864,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28052	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3681	758.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2464	2464	A	910	A	854	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28052	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3681	758.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3016	3016	C	833	C,A	794,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2098	folP	855	855	100.0	folP.l15.c4.ctg.1	1537	135.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1043	1045	AGC	198;201;201	A;G;C	188;189;191	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5370	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3319	160.7	1	SNP	p	S91F	1	.	.	271	273	TTC	530	532	TTC	181;182;181	T;T;C	170;171;167	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5370	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3319	160.7	1	SNP	p	D95G	1	.	.	283	285	GGC	542	544	GGC	182;186;188	G;G;C	165;173;175	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5370	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3319	160.7	1	SNP	p	G95N	0	.	.	283	285	GGC	542	544	GGC	182;186;188	G;G;C	165;173;175	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1676	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1474	113.1	1	SNP	p	G45D	0	.	.	133	135	GGC	527	529	GGC	192;190;189	G;G;C	179;177;178	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	814	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	936	86.2	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	162	A	156	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	166.8	1	SNP	p	D86N	0	.	.	256	258	GAC	560	562	GAC	185;184;186	G;A;C	174;173;174	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	166.8	1	SNP	p	S87R	1	.	.	259	261	CGT	563	565	CGT	185;184;184	C;G;T	173;171;173	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	166.8	1	SNP	p	R87I	0	.	.	259	261	CGT	563	565	CGT	185;184;184	C;G;T	173;171;173	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	166.8	1	SNP	p	R87W	0	.	.	259	261	CGT	563	565	CGT	185;184;184	C;G;T	173;171;173	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	166.8	1	SNP	p	S88P	0	.	.	262	264	TCC	566	568	TCC	186;188;191	T;C;C	175;179;181	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4248	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2569	164.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	233;234;233	G;G;C,G	214;211;210,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1237	1239	GCA	216;217;220	G;C;A	205;201;207	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1240	1242	ATC	219;219;219	A;T;C	207;207;207	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1252	1254	GTG	212;212;211	G;T;G	205;202;204	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1252	1254	GTG	212;212;211	G;T;G	205;202;204	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1756	1758	ACC	222;221;221	A;C;C,T	201;202;203,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1810	1812	GCG	216;214;211	G;C;G,A	194;173;179,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1810	1812	GCG	216;214;211	G;C;G,A	194;173;179,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1933	1935	AGC	198;198;196	A;G;C	187;186;184	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1942	1944	GGC	187;190;191	G;G;C	175;179;177	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2324	179.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1960	1962	CCG	165;167;169	C,G;C;G	111,6;117;120	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5702	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3117	181.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1736	1738	CCG	185;183;182	C;C;G	166;168;167	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2214	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1814	121.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	596	596	C	143	C	137	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1439	199.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	881	881	T	204	T	191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1439	199.4	1	SNP	p	G120K	0	.	.	358	360	GGT	608	610	GGT	242;242;241	G;G;T	230;227;224	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1439	199.4	1	SNP	p	A121D	0	.	.	361	363	GCC	611	613	GCC	239;242;245	G,A;C,T;C	221,2;224,1;230	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1439	199.4	1	SNP	p	A121N	0	.	.	361	363	GCC	611	613	GCC	239;242;245	G,A;C,T;C	221,2;224,1;230	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11056	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4973	221.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1204	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	916	130.2	1	SNP	p	V57M	1	.	.	169	171	ATG	523	525	ATG	255;260;260	A;T;G	245;247;248	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
